Danaher Beats Q2 Revenue, EPS Forecasts

Global science and technology innovator (NYSE:DHR) reported second quarter 2025 results on Tuesday, July 22, that topped analysts' consensus expectations. Q2 revenue of $5.94 billion came in above the $5.84 billion estimate, and adjusted EPS reached $1.80 versus the $1.64 analysts expected. On the bottom line, net earnings fell to $555 million from $907 million in the prior year quarter, while adjusted EPS rose 4.7% year over year.

Ongoing operational discipline and some ongoing challenges in Life Sciences and Diagnostics were noted. Overall, the quarter saw moderate growth and improved profitability, allowing leadership to increase its full-year adjusted EPS outlook. However, several metrics, including cash flow and Life Sciences performance, showed pressure.

Source: Danaher. Note: Analyst consensus estimates for the quarter provided by FactSet.

Continue reading

Source Fool.com